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Abstract: Helichrysum plicatum DC. is widely used in folk medicine in treating a variety of health
disorders. The aim of this study was to examine the influence of different extraction solvents on the
chemical composition, antioxidant potential, and antimicrobial activities of H. plicatum. Aerial parts
were separately extracted with ethanol, dichloromethane, and sunflower oil. The oil extract (OE)
was re-extracted with acetonitrile. A total of 142 compounds were tentatively identified in ethanolic
(EE), dichloromethane (DCME), and acetonitrile (ACNE) extracts using HPLC-DAD/ESI-ToF-MS. The
dominant compound class in all extracts were α-pyrones, alongside flavonoids in EE, terpenoids
in DCME and ACNE, and phloroglucinols in DCME. The antioxidant potential of the extracts was
assessed by the 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) assay. EE and DCME possessed the
most potent radical scavenging capacity. Antimicrobial activity was investigated on eight bacterial,
two yeast, and one fungal species. All extracts exhibited high antifungal and notable antibacterial
activities compared to control substances, with DCME being the most potent. DCME exhibited
stronger antimicrobial activity against P. aeruginosa than the standard chloramphenicol.
Keywords: Helichrysum plicatum; antioxidant potential; antimicrobial activity; solvent polarity;
phenols; liquid chromatography-mass spectrometry (LC-MS)
1. Introduction
The genus Helichrysum Miller (Asteraceae) comprises about 600 species of perennial or annual
herbs or shrublets distributed in Europe, Asia, and Africa, the plant parts of which have been
traditionally used as infusions or decoctions in the treatment of diverse ailments [1,2]. Interest in
phytochemical and pharmacological studies of this genus has increased in recent years. Helichrysum
species represent an abundant source of secondary metabolites, such as flavonoids, chalcones, phenolic
acids, phthalides, coumarins, pyrones, and terpenes [1]. Plant extracts and their chemical constituents
exhibit a range of biological activities, including antioxidant, anti-inflammatory, wound-healing,
antimicrobial, photoprotective, anticarcinogenic, etc. [3–12].
Helichrysum plicatum DC. is a herbaceous perennial plant, which is native to the Balkan and
Anatolian Peninsulas and Iran [13]. It has been used in folk medicine for wound-healing and the
treatment of gastric and hepatic disorders, diabetes, and kidney stones [14–16]. Chemically, this species
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was mostly studied for its phenolic, mainly flavonoid content, which is thought to be responsible for
the therapeutic effects of the plant. H. plicatum polar extracts are reported to possess antimicrobial,
antidiabetic, spasmolytic, nephroprotective, and antimutagenic activities [13,17–21].
It is apparent that extracts from the same plant will differ in their composition of bioactive
compounds depending on the extraction solvent. Since, with the exception of the essential oil, only the
phenolic composition of polar extractives has been investigated in H. plicatum to date, the aim of this
study was to perform a more detailed chemical analysis of the plant and to examine the influence of
solvents of different polarity on the extraction yield, composition of extracts, antioxidant potential, and
antimicrobial activities.
2. Results
2.1. Phytochemical Profile
Aerial parts of wild H. plicatum at the full blooming stage were extracted with solvents of different
polarity. The yields were 7.14%, 2.88%, and 0.62% for ethanol (EE), dichloromethane (DCME), and
acetonitrile oil (ACNE) extracts, respectively. The phytochemical content of the extracts was assessed
by HPLC-DAD/ESI-ToF-MS. The peaks in chromatograms were tentatively identified on the basis of
the exact molecular masses and formulas, UV spectra, and literature data (Tables S1–S3, Supplementary
Material). The total ion chromatograms (TIC) in the positive (for EE and DCME) and negative (for EE,
DCME and ACNE) modes and HPLC-DAD chromatograms of the investigated extracts are shown in
the Supplementary Material (Figures S1–S3).
A total of 142 compounds were identified in H. plicatum aerial parts. Their distribution in the
different extracts is presented in Table 1. The indicated structures are in agreement with the literature
on Helichrysum species and/or the Asteraceae family [4,22–106] (Figure 1). All the extracts were
characterized by α-pyrones. Simple α-pyrones (such as micropyrone and compound 1), homodimers
(helipyrone, bisnorhelipyrone), as well as heterodimers of α-pyrones and phloroglucinols (arenol,
arzanol, heliarzanol, auricepyrone, etc.) were found. The prevailing compounds in EE were flavonoids.
Four classes of flavonoids were identified: flavones, flavanones, flavonols, and chalcones. Compared
to DCME and ACNE, only EE contained glycosylated flavonoids (compounds 43, 44, 58–60, 63–65, 67,
68, 70–72). Being more hydrophilic than their aglycone counterparts because of the presence of sugar
moieties, glycosides are easily extracted with polar protic solvents. α-Pyrones and terpenoids were
predominant in both ACNE and DCME, while DCME also possessed phloroglucinols as dominant
compounds (Table 1). An interesting feature of nonpolar DCM and ACN extracts is the presence of
(poly)methoxylated flavones, i.e. dimethoxy- (49, 53) and pentamethoxyflavones in DCME (46, 47)
and methoxy- (51, 52), dimethoxy- (50), and triethoxy-dimethoxy flavones in ACNE (54, 55, 57).
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Figure 1. Phenolic representatives of H. plicatum: (a) naringenin (flavanone), (b) isosalipurposide 
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Figure 1. Phenolic representatives of H. plicatum: (a) naringenin (flavanone), (b) isosalipurposide
(chalcone), (c) chlorogenic acid (phenolic acid ester), (d) 5,7-dihydroxyphthalide (phthalide), (e)
plicatipyrone (chromanyl α-pyrone).
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Table 1. Composition of H. plicatum ethanol (EE), dichloromethane (DCME), and acetonitrile oil (ACNE) extract analysed by HPLC-DAD/ESI-ToF.
No Compound Class/Name EE DCME ACNE
Pyrone
α-pyrone
1 6-ethyl-4-hydroxy-5-methyl-3-(3-oxopentyl)-2H-pyran-2-one [22] +
2 micropyrone [23] +
3 micropyrone analog [19] +
4 helipyrone C [20] + + +
5 bisnorhelipyrone [21] +
6 plicatipyrone analog [22] +
7 3,3’-methylenebis[4-(acetyloxy)-5,6-dimethyl-2H-pyran-2-one [21] +
8 helipyrone B [20] +
9 3-[[3-acetyl-2,4,6-trihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]methyl]-4-hydroxy-6-methyl-2H-pyran-2-one [19] +
10 plicatipyrone [22] + + +
11 arenol [23] + + +
12 plicatipyrone analog [22] +
13 arzanol [27] + + +
14 heliarzanol [23] + +
15 cycloarzanol [23] +
16 helipyrone diacetate [25] + +
17 methylarzanol [23] + +
18 3-[1-[3-acetyl-2,4,6-trihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]ethyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [23] + +
19 auricepyrone [22], 23-methyl-6-O-desmethylauricepyrone [22] +
20 helicerastripyrone [28] +
21 4-hydroxy-5,6-dimethyl-3-[[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxobutyl)phenyl]methyl]-2H-pyran-2-one [24] +
22 3-[[3-acetyl-5-(3,7-dimethyl-2,6-octadien-1-yl)-2,4,6-trihydroxyphenyl]methyl]-4-hydroxy-5,6-dimethyl-2H-pyran-2-one [29] +
23 plicatipyrone analog [26] + +
24 6-ethyl-4-hydroxy-5-methyl-3-[[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)phenyl]methyl]-2H-pyran-2-one [23] + +
25 norauricepyrone [24] +
26 3-[[2,4-dihydroxy-6-methoxy-3-(2-methyl-1-oxobutyl)phenyl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [30] +
27
3-[1-[3-acetyl-2,4,6-trihydroxy-5-(3-methyl-2-buten-1-yl)phenyl]heptyl]-4-hydroxy-6-methyl-2H-pyran-2-one [23],
3-[[2,4-dihydroxy-6-methoxy-5-(3-methyl-2-buten-1-yl)-3-(2-methyl-1-oxobutyl)phenyl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [30],
3-[[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxobutyl)phenyl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [22]
+ +
28 3-[[3-acetyl-5-(3,7-dimethyl-2,6-octadienyl)-2,4,6-trihydroxyphenyl]methyl]-4-hydroxy-5-methyl-6-propyl-2H-pyran-2-one [29],3-[[3-(3,7-dimethyl-2,6-octadien-1-yl)-2,4,6-trihydroxy-5-(2-methyl-1-oxopropyl)phenyl]methyl]-4-hydroxy-5,6-dimethyl-2H-pyran-2-one [24] +
29 3-[[3-(3,7-dimethyl-2,6-octadien-1-yl)-2,4,6-trihydroxy-5-(2-methyl-1-oxobutyl)phenyl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [24] +
30 3-[[3,7-dimethyl-2,6-octadien-1-yl]-2,4,6-trihydroxy-5-(2-methyl-1-oxobutyl)phenyl]methyl]-4-hydroxy-5,6-dimethyl-2H-pyran-2-one [24] + +
31 3-[[2,3-dihydro-4,6-dihydroxy-2-(1-methylethenyl)-5-(2-methyl-1-oxobutyl)-7-benzofuranyl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one[30], 3-[[5,7-dihydroxy-2,2-dimethyl-6-(2-methyl-1-oxobutyl)-2H-1-benzopyran-8-yl]methyl]-6-ethyl-4-hydroxy-5-methyl-2H-pyran-2-one [30] +
Plants 2020, 9, 337 4 of 20
Table 1. Cont.
No Compound Class/Name EE DCME ACNE
32 2’,3’-dihydroxypuberulin [31] +
33 7-(2,3-dihydroxy-3-methylbutoxy)-5-hydroxy-6-methoxy-2H-1-benzopyran-2-one [32] + +
34 coumarin derivative [33,34] +
35 7-(2,3-dihydroxy-3-methylbutoxy)-5,6-dimethoxy-2H-1-benzopyran-2-one [35] +
36 2,3-dihydro-10-methoxy-2-(1-methylethenyl)-7H-pyrano[2,3-g]-1,4-benzodioxin-7-one [36] +
37 2-methoxy-3,5-dimethyl-6-(1-methylethyl)-4H-pyran-4-one [30] +
38 3-[[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxobutyl)phenyl]methyl]-6-ethyl-2-methoxy-5-methyl-4H-pyran-4-one [37] +
39 italipyrone [22] +
40 italipyrone analog [22] +
γ-pyrone (chromone)
41 3-(acetyloxy)-2,3-dihydro-5,7-dihydroxy-6-(3-methyl-2-butenyl)-2-phenyl-4H-1-benzopyran-4-one [38] +
42 2,3-dihydro-5,7-dihydroxy-3-methyl-8-(3-methyl-2-butenyl)-2-(1-methylethyl)-4H-1-benzopyran-4-one [39] +
Flavonoid
flavone
43 apigenin-7-O-glucoside [4] +
44 apigenin-5-O-glucoside [40] +
45 luteolin [41] +
46 3,5,6,7,8-pentamethoxyflavone [42] +
47 3’,4’,5,6,7-pentamethoxyflavone [43] +
48 apigenin [40] +
49 dihydroxy-dimethoxyflavone [44] +
50 jaceosidin [45] +
51 chrysoeriol [45] +
52 5,7-dihydroxy-3-methoxyflavone [44] +
53 5,7,4’-trihydroxy-3,6-dimethoxy-3’-prenylflavone [46] +
54 TEDMF 1 [43] +
55 TEDMF [43] +
56 6-[(6-ethyl-4-hydroxy-5-methyl-2-oxo-2H-pyran-3-yl)methyl]-2,3-dihydro-5,7-dihydroxy-8-(3-methyl-2-buten-1-yl)-2-phenyl-4H-1-benzopyran-4-one[47] +
57 TEDMF [43] +
flavanone
58 naringenin-5-O-glucoside [40] +
59 naringenin-4′-O-glucoside [48] +
60 naringenin-7-O-glucoside [40] +
61 eriodictyol [49] +
62 naringenin [40] + +
flavonol
63 quercetin-3-O-glucoside [4], hyperoside (quercetin-3-O-galactoside) [4] +
64 kaempferol-3-O-glucoside [50] +
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Table 1. Cont.
No Compound Class/Name EE DCME ACNE
65 helichrysoside [51] +
66 quercetin [40] + +
67 tiliroside [52] +
68 tiliroside analog [52] +
69 kaempferol [41] +
chalcone
70 arenariumoside V [53], arenariumoside VI [53], arenariumoside VII [53] +
71 tomoroside A [53] +
72 isosalipurposide [40] +
73 helilupolone [54] +
Terpenoid
sesquiterpenoid
74 sesquiterpene derivative [55–57] +
75 sesquiterpene derivative [55–57] +
76 sesquiterpene derivative [58–60] +
77 sesquiterpene derivative [61,62] +
78 sesquiterpene derivative [62–64] +
79 eudesmane derivative [65] +
80 sesquiterpene derivative [66–68] +
81 sesquiterpene derivative [66–68] +
82 ainsliaside E [69] +
83 cinnamoyloxy-hydroxyeudesmane [70] +
84 athrolide C [71] + +
85 athrolide D [71] +
diterpenoid
86 diterpene derivative [30,72] +
87 8-(acetyloxy)-3-ethenyloctahydro-10-hydroxy-3,4a,7,7,10a-pentamethyl-1H-naphtho[2,1-b]pyran-2,5(3H,4aH)-dione [72] +
88 (7-ethenyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-1,4a,7-trimethyl-1-phenanthrenyl)methyl-butanedioic acid methyl ester [72] +
89 ent-kaurane derivative [73] +
90 gymnospermin [74] +
91 diterpene derivative [75–77] +
92 ent-kaurane derivative [73] +
93 5-(acetyloxy)-α-ethenyldecahydro-α,3a,5,7b-tetramethyl-1H-cyclopropa[a]naphthalene-4-propanol acetate [78] +
94 ent-kaurane derivative [73] + +
Phloroglucinol
95 4-[3,5-dihydroxy-4-(1-oxobutyl)phenoxy]-2-methyl-butanoic acid [47], 4-[3,5-dihydroxy-4-(2-methyl-1-oxopropyl)phenoxy]-2-methyl-butanoic acid[47], 1-[2,6-dihydroxy-4-[[4-hydroxy-3-(hydroxymethyl)-2-buten-1-yl]oxy]phenyl]-1-butanone [47] +
96 2,3-dihydro-4,5-dimethoxy-2,2-dimethyl-6-benzofuranol [79] +
97 4,5-dimethoxy-6-(2-methyl-1-propen-1-yl)-1,3-benzenediol-1,3-diacetate [79] +
98 1-(4,6-dihydroxy-2,3-dimethoxyphenyl)-2-methyl-1-butanone [43,79,80] +
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Table 1. Cont.
No Compound Class/Name EE DCME ACNE
99 4-[3,5-dihydroxy-4-(2-methyl-1-oxopropyl)phenoxy]-2-methyl-2-butenoic acid methyl ester [47] +
100 acylphloroglucinol derivative [47] + +
101
2-methyl-1-[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-1-propanone [47],
1-[2,6-dihydroxy-4-[(3-methyl-2-buten-1-yl)oxy]phenyl]-2-methyl-1-propanone [47],
1-[2,6-dihydroxy-4-[(3-methyl-2-buten-1-yl)oxy]phenyl]-1-butanone [47], 1-[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-1-butanone [47],
1-(3,4-dihydro-5,7-dihydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-2-methyl-1-propanone [30]
+
102 [3,4-dihydro-5,7-dihydroxy-2-(4-methyl-3-penten-1-yl)-2H-1-benzopyran-6-yl]phenyl-methanone [81] + +
103 2-(3,7-dimethyl-2,6-octadienyl)-3-hydroxy-5-methoxy-6-(2-methyl-1-oxopropyl)-2,5-cyclohexadiene-1,4-dione [30] +
104 phenyl[2,4,6-trihydroxy-3-(3-methyl-2-buten-1-yl)phenyl]-methanone [47],[2,6-dihydroxy-4-[(3-methyl-2-buten-1-yl)oxy]phenyl]phenyl-methanone [47] +
105 1-[2,3-dihydro-4,6-dihydroxy-2-(1-methylethenyl)-5-benzofuranyl]-2-methyl-1-propanone [30] +
106 7-acetyl-5’-ethyl-4,6-dihydroxy-4’-methyl-5-(3-methyl-2-buten-1-yl)-spiro[benzofuran-2(3H),2’(3’H)-furan]-3’-one [24] + +
107 1-[2,6-bis(acetyloxy)-4-[[4-(acetyloxy)-3-[(acetyloxy)methyl]-2-buten-1-yl]oxy]phenyl]-1-butanone [47] + +
108 4,6-dihydroxy-4’,5’-dimethyl-5-(3-methyl-2-buten-1-yl)-7-(2-methyl-1-oxobutyl)-spiro[benzofuran-2(3H),2’(3’H)-furan]-3’-one [24],5’-ethyl-4,6-dihydroxy-4’-methyl-5-(3-methyl-2-buten-1-yl)-7-(2-methyl-1-oxopropyl)-spiro[benzofuran-2(3H),2’(3’H)-furan]-3’-one [24] +
109 2-methyl-1-[2,4,6-trihydroxy-5-[(1S)-1-(4-hydroxy-6-methoxy-1,3-benzodioxol-5-yl)-2-methylpropyl]-3-(3-methyl-2-butenyl)phenyl]-1-propanone [30] +
Phthalide
110 7-(β-D-glucopyranosyloxy)-5-hydroxy-1(3H)-isobenzofuranone [82] +
111 5,7-dihydroxyphthalide [83] + +
112 7-(β-D-glucopyranosyloxy)-5-methoxy-phthalide [83] +
113 5-methoxy-7-hydroxyphthalide [84] + +
114 4-(4-hydroxy-3-methylbutyl)-5,7-dimethoxy-1(3H)-isobenzofuranone [85] +
Phenolic acid (derivative)
115 chlorogenic acid [86] +
116 caffeic acid [87] +
117 everlastoside M [88] +
118 syringic acid [87] +
119 3’,4’-methylenedioxycinnamic acid [89] +
120 di-O-caffeoylquinic acid [4] +
121 di-O-caffeoylquinic acid [4] +
122 4-(3-methoxy-3-oxo-1-propen-1-yl)-2-(3-methyl-2-buten-1-yl)phenyl-3-(acetyloxy)-butanoic acid ester [90] +
Acetophenone
123 4’-hydroxy-3’-(3-methyl-2-butenyl)-acetophenone [26] +
124 1-[2-[1-[(acetyloxy)methyl]ethenyl]-2,3-dihydro-3-hydroxy-5-benzofuranyl]ethanone [51] + +
Other
125 inositol [83] +
126 quinic acid [91] +
127 1,6-dihydroxy-4-oxo-2-cyclohexene-1-acetic acid methyl ester [92] +
128 tetrahydrojacarone [93] +
129 loliolide [94] +
130 2-[4-(1,3-dihydroxypropyl)-2-methoxyphenoxy]-3-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-propanone [95] +
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No Compound Class/Name EE DCME ACNE
131 pinellic acid [96], tianshic acid [97] + +
132 (3,4,5,6,7-pentamethoxy-2-benzofuranyl)phenylmethanone [98] +
133 PUFA 2 [99–101] +
134 pinoresinol [102] +
135 PUFA [99–101] +
136 dihydro-5-(5,8-tetradecadienyl)-2(3H)-furanone [47] +
137 PUFA [99–101] + +
138 hexadecanal [103] +
Unclassified 3
139 4-hydroxy-3,5-dimethyl-6-(1-methylethyl)-2H-pyran-2-one [30], 2-ethyl-6-methoxy-3,5-dimethyl-4H-pyran-4-one [28] +
140 3-prenyl-2,4,6-trihydroxyacetophenone [30], 4,6-dimethoxy-5-(2-methyl-1-propen-1-yl)-1,3-benzodioxole [80] + +
141 helinivene A [104], piperitol [105], 1-[6-(acetyloxy)-2,3,4-trimethoxyphenyl]-3-phenyl- 2-propen-1-one [106] +
142 ent-kaurane derivative [73], eudesmane derivative [65] +
1 triethoxy-dimethoxy-flavone; 2 polyunsaturated fatty acid; 3 presumed compounds for one formula which belongs to different classes are listed as unclassified.
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2.2. Antioxidant Potential
The antioxidant activity of H. plicatum extracts was assessed by the 2,2-diphenyl-1-picrylhydrazyl
(DPPH) radical assay (Table 2). EE, DCME, and ACNE demonstrated significant DPPH scavenging
activity. The analysed extracts could not be compared since the polar extract (EE) was analysed
by the polar DPPH method (DPPH in methanol) and nonpolar extracts (DCME, ACNE, and OE)
were analysed by the nonpolar DPPH method (DPPH in toluene). However, after comparison with
standards analysed by the same method, we concluded that the DCME extract exhibited a stronger
antioxidant potential than the BHT standard (toluene), while EE exhibited slightly lower activity than
BHT (methanol) and Trolox.
Table 2. DPPH free radical scavenging activities of H. plicatum ethanol (EE), dichloromethane (DCME),
acetonitrile oil (ACNE), and oil extracts (OE); BHT—butylated hydroxytoluene.
EE DCME ACNE OE Trolox BHT (Methanol) BHT (Toluene)
EC50 1 (mg/mL) 0.45 ± 0.04 0.58 ± 0.02 1.74 ± 0.01 17.61 ± 0.16 0.064 ± 0.01 0.33 ± 0.01 1.42 ± 0.01
1 Data are presented as mean ± standard deviation (n = 3).
2.3. Antimicrobial Activity
The antimicrobial activity of H. plicatum was investigated against five Gram-negative bacteria
(Escherichia coli, Pseudomonas aeruginosa, Proteus hauseri, Klebsiella pneumoniae, Salmonella enterica subsp.
enterica), three Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis, Clostridium sporogenes),
two yeasts (Candida albicans, Saccharomyces cerevisiae), and one fungal strain (Aspergillus brasiliensis)
(Tables 3–5). All the extracts displayed notable antibacterial activity in the range of 0.157–2.5 mg/mL.
DCME was more active than the chloramphenicol standard against Pseudomonas aeruginosa. In addition,
DCME demonstrated the best antibacterial activity among the extracts, as indicated by the lowest
minimal inhibitory concentration (MIC) values. The tested extracts exhibited better or the same
antifungal activity as compared to the commercial drug nystatin. Once more, DCME had the lowest
MIC values.
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Table 3. Antibacterial activity of H. plicatum ethanol (EE), dichloromethane (DCME), and acetonitrile oil (ACNE) extract against Gram-negative bacteria.
Escherichia coli Pseudomonas aeruginosa Proteus hauseri Klebsiella pneumoniae Salmonella enterica subsp. enterica
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
mg/mL mg/mL mg/mL mg/mL mg/mL
EE 2.5 >10 0.625 2.5 2.5 >10 1.25 5 2.5 5
DCME 0.313 2.5 0.157 1 0.625 0.157 0.625 0.157 0.625 1.25 10
ACNE 0.625 2.5 1.25 5 1.25 5 0.625 1.25 1.25 5
Chloramphenicol 0.062 0.25 0.125 0.062 0.125
1 MIC value lower than the control.
Table 4. Antibacterial activity of H. plicatum ethanol (EE), dichloromethane (DCME), and acetonitrile oil (ACNE) extract against Gram-positive bacteria.
Staphylococcus aureus Bacillus subtilis Clostridium sporogenes
MIC MBC MIC MBC MIC MBC
mg/mL mg/mL mg/mL
EE 0.313 2.5 0.313 1.25 2.5 10
DCME 0.157 0.625 0.157 0.625 0.313 1.25
ACNE 0.625 5 2.5 10 2.5 10
Chloramphenicol 0.015 0.015 0.25
Table 5. Antifungal activity of H. plicatum ethanol (EE), dichloromethane (DCME), and acetonitrile oil (ACNE) extract.
Aspergillus brasiliensis Saccharomyces cerevisiae Candida albicans
MIC MFC MIC MFC MIC MFC
mg/mL mg/mL mg/mL
EE 1.25 1 >10 1.25 10 2.5 5
DCME 0.625 2.5 1.25 5 1.25 2.5
ACNE 1.25 10 1.25 10 2.5 5
Nystatin 2.5 1.25 2.5
1 MIC values lower than the control are bolded.
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3. Discussion
3.1. Phytochemical Profile
The predominant compounds in EE were flavonoids and their glycosylated derivatives. Luteolin
(compound 45, Table 1), naringenin (62), apigenin (48), quercetin (66), kaempferol (69), as well as
naringenin-, apigenin-, and kaempferol- glucosides (58–60, 43, 44, 64) have been previously reported
in H. plicatum [14,107]. These compounds are probably the main contributors to the therapeutic effects
of the plant, which are used for treating hepatic and gastric disorders. In addition, the same flavonoids
found in H. arenarium, which are reported to exhibit choleretic, cholagogue, hepatoprotective, and
detoxifying activities, are also present in H. plicatum [107]. Furthermore, the phenolic-rich extracts
of H. plicatum, with the glycosides of naringenin, apigenin, quercetin, and kaempferol as the main
compounds, followed by their aglycones and chlorogenic acid, exhibited potent cytotoxic activities
against human cancer cell lines [108]. Flavonoids and other phenolic constituents of water and
ethanol extracts are also thought to be responsible for the antidiabetic and spasmolytic effects of this
plant [17,18].
DCME and ACNE were characterized by the presence of α-pyrones. Numerous diverse pyrones
were isolated from Helichrysum spp., although they were poorly analysed in H. plicatum. Plicatipyrone
(10) was previously isolated from this species [22]. Akaberi et al. [1] listed several different groups of
α-pyrone derivatives that are distributed in Helichrysum spp., namely monomers, glycosylated forms,
homo-, and heterodimers. The α-pyrone profile tentatively determined in H. plicatum in the present
study corresponds to α-pyrones found in other Helichrysum species. Vrkocˇ et al. [27] characterized the
yellow pigment from the flowers of H. arenarium as a mixture of two heterodimers—phloroglucinyl
α-pyrones arenol (11) and homoarenol (later named arzanol [109], 13). Arzanol is probably the
most investigated α-pyrone from Helichrysum spp. It has been reported to possess a variety of
pharmacological activities, including antioxidant, anti-inflammatory, and anti-HIV [109–111].
Several alkoxy-flavone derivatives were detected in DCME and ACNE. O-alkylation increases
the lipophilicity and bioavailability of these natural products. To the best of the authors’ knowledge,
there are no previous records of these derivatives in H. plicatum, probably because this species was
mostly studied for the phenolic content of more polar extracts [4,86,112,113]. Methoxylated flavones
were, however, reported in other Helichrysum species, such as H. viscosum var. bracteatum [43], H.
decumbens [29], H. foetidum [114], H. italicum [115], H. kraussii [116], H. melaleucum [102], H. nitens [42],
H. odoratissimum [116], and H. picardii [115].
3.2. Antioxidant Potential
The results obtained in this work are in agreement with literature data indicating that the methanolic
and ethanolic extracts of H. plicatum exhibit dose-dependent antioxidant activity. Antioxidant activity
was attributed to the phenolic content of the extracts, mostly phenolic acids and flavonoids [87,108].
These compounds act by inhibiting enzymes or chelating trace elements involved in reactive oxygen
species generation or by reducing highly-oxidizing free radicals through hydrogen atom donation [117,
118]. The phenolic radicals generated in the process of free radical scavenging can be stabilized via
intramolecular hydrogen bonds and by electron delocalization in the aromatic ring.
Comparison of the EC50 values with literature data obtained by different protocols and DPPH
concentrations is not consistent. Kadifkova Panovska and Kulevanova [119] reported EC50 values in
the range 6–11 mg/mL for H. plicatum methanol and ethanol extracts with 100 mM DPPH, while 37–88
µg/mL EC50 values with 0.08 mM DPPH were reported by Bigovic´ et al. [108] and 235–918 µg/mL
with 0.1 mM DPPH by Acet et al. [120]. Even though 0.1 mM DPPH was used in the present study,
the results are still difficult to compare with Acet et al. because of the different mixing volumes of
extracts and DPPH solutions, as well as the different incubation times. Nevertheless, compared to
Trolox, the results presented herein are similar to the results from a previous study [108], whereas
compared to BHT, the extracts from the present study (EE, DCME, and ACNE) were more potent in
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radical scavenging than the methanol and ethanol extracts of H. plicatum investigated by Kadifkova
Panovska and Kulevanova [119].
The most potent radical scavenging capacity in the present study was exhibited by EE and DCME,
which are both rich in α-pyrones. Rosa et al. [110] showed that the α-pyrones arzanol and helipyrone
achieved remarkable efficacy in scavenging lipid peroxyl radicals. Since arzanol (Figure 2) showed
powerful scavenging activity against linoleic acid peroxyl radicals in the linoleic acid autoxidation
test and methylarzanol was only slightly active, the authors concluded that the α-pyrone enolic
hydroxyl, which can mimic a phenolic hydroxyl in assays of antioxidant activity, is responsible for the
observed radical scavenging properties [110]. Furthermore, arzanol exhibited antioxidant properties at
non-cytotoxic concentrations [121], which qualifies it as a candidate for investigation as a possible food
additive. The presence of flavonoids probably also contributed to the significant antioxidant potential
of EE.
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3.3. Antimicrobial Activity
There are several studies on H. plicatum antimicrobial activity, which was ascribed to the phenolic
and flavonoid contents [13,120,122]. Fungi were more sensitive to H. plicatum extracts than bacteria,
which corroborates our findings. In previous studies, Gram-positive bacteria were more sensitive to the
tested extracts than Gram-negative bacteria, although this pattern was not observed in the present study.
In general, polyphenols have been widely investigated for their antimicrobial activities, which can be
attributed to both direct action against microorganisms as well as the suppression of icrobial virulence
factors [123]. In this study, all extracts contained a variety of phenolic compounds. Furthermore, ACNE
and DCME were characterized by the presence of (poly)methoxylated flavones. Methoxylated flavones
from H. nitens displayed antifungal activity against Cladosporium cucumerinum [42]. This group of
compounds is reported to exhibit mild antibacterial but potent fungicidal properties [124,125]. They are
externally located on leaf and stem surfaces where they presumably play a role in antimicrobial defence.
Methylation decreases the antioxidant potential but increases the stability of flavones, their lipophilicity,
and, consequently, the ability to permeate membranes [126]. The presence of polymethoxylated
flavonoids was confir ed herein in DCME, and it can be assumed that nonpolar flavonoids were
responsible for the pronounced antifungal activity of this extract.
The main compounds of DCME, the most active extract in the antimicrobial tests, were α-pyrones,
terpenoids, and phloroglucinols. The terpenoid components from H. italicu , along with flavonoids,
were responsible for the antimicrobial properties of the plant [127]. Antimicrobial activity of α-pyrones
from Helichrysum species has also been demonstrated. Four heterodimeric (italipyrone, plicatipyrone,
arenol, and arzanol) and three homodimeric (helipyrone and two related compounds) α-pyrones from
H. stoechas, which were identified in the H. plicatum investigated herein, displayed high activities
against Gram-positive bacteria [26]. In another study, arzanol showed outstanding action against
multidrug-resistant Staphylococcus aureus isolates, making it a good choice for further studies of
suppression of antibiotic-resistant bacterial strains [23], while phloroglucinyl α-pyrones from H.
decumbens displayed significant antifungal activity against Cladosporium herbarum [29].
The variety of compounds identified in H. plicatum most probably exert synergistic effects.
Antioxidants and antimicrobials from natural sources have gained popularity over synthetic ones in
the last twenty years because they most likely exhibit fewer side effects. Arenarin, which represents a
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mixture of phenolic antibiotics from H. arenarium, a plant with a similar phytochemical content to H.
plicatum, is used as a skin and eye antibacterial agent in Russia [23]. Owing to the important biological
activities of H. plicatum extracts and isolated compounds, they could be considered for use in the
pharmaceutical, cosmetic, and food industries.
4. Materials and Methods
4.1. Plant Material
A commercial sample of wild-growing plant material was obtained from the Institute for Medicinal
Plants Research “Dr. Josif Pancic´”, Belgrade, Serbia. Wild-growing plant material was collected during
the full-blooming stage in Macedonia in 2017.
4.2. Extraction Procedure
The dried and powdered plant material was extracted with 96% ethanol, dichloromethane,
and sunflower oil in the dark for seven days. After filtration, solvent was removed from ethanol
and dichloromethane extracts. In order to avoid ionization difficulties with the oil matrix, prior to
HPLC-DAD/ESI-ToF-MS analyses, the oil extract was re-extracted with acetonitrile by overhead rotary
mixer for 18 h.
4.3. HPLC-DAD/ESI-ToF-MS Analyses
Prior to injection, the test samples were dissolved in methanol (c ≈ 10 mg/mL) and filtered through
a 0.45-µm filter.
An HPLC apparatus (Agilent 1100 Series, Agilent Technologies) with a degasser, autosampler,
LiChrospher 100 RP18e column (250 × 4.0 mm i.d.; 5 µm), and a DAD detector in combination with a
6210 Time-of-Flight LC/MS system (Agilent Technologies) was used to analyse the chemical content of
the tested samples. A mixture of solvents A (0.2% formic acid solution in water) and B (acetonitrile)
with programmed isocratic and gradient elution was used as the mobile phase: 0–5 min 10–20% B, 5–10
min 20% B, 10–20 min 20–30% B, 20–30 min 30–70% B, 30–35 min 70–100% B, 35–40 min 100% B, 40–41
min 100–10% B, 41–45 min 10% B at a flow rate of 1.00 mL/min. The injection volume was 10 µL and the
column temperature was 25◦C. A DA detector was used to detect signals in the 190–550 nm wavelength
range. The charged molecular ions were obtained by electrospray ionization (ESI) at atmospheric
pressure: the eluted compounds were mixed with nitrogen in the heated interface and the polarity was
set to negative, with the following ES parameters: capillary voltage, 4000 V; gas temperature, 350◦C;
drying gas flow rate, 12 L/min; nebulizer pressure, 45 psig (310.26 Pa); fragmentation voltage, 140 V,
and masses were measured in the range 100–2500 m/z. MassHunter Workstation software was used for
data recording and processing.
4.4. Antioxidant Assay
The antioxidant activity of the plant extracts was evaluated by the 2,2-diphenyl-1-picrylhydrazil
(DPPH) assay [128], which is based on the depletion of the colour of the stable free radical DPPH
in a reaction with potential antioxidants and measured by the decrease of absorbance at 517 nm.
Concentrations of the extracts were in the range from 0.1 to 1.75 mg/mL. A volume of 200 µL was
mixed with 1800 µL of a methanolic solution of DPPH (0.1 mM). The reaction mixture was shaken and
then incubated in the dark for 30 min. After this period, the absorbance of the remaining DPPH radical
was measured at 517 nm (Asample). Blank probes were done in the same way, using 200 µL of methanol
instead of the extract solution to obtain Ablank. All determinations were performed in triplicate. The
percentage of inhibition of the DPPH radical, I(%), by each sample was calculated according to the
equation:
I(%) =
Ablank −Asample
Ablank
× 100.
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The EC50 (concentration of an extract that reduces the absorption of DPPH solution by 50%) was
calculated from the curve of the dependence of I(%) from the concentration of each extract. DPPH
scavenging activity was also determined for Trolox and butylated hydroxytoluene (BHT), which are
known artificial antioxidants that were used as positive probes. Tests were performed in triplicate.
The same procedure was undertaken for the determination of the radical scavenging capacity
of oil extracts, except that toluene instead of methanol was used as a solvent, and BHT dissolved in
toluene as a positive probe.
4.5. Antimicrobial Assay
Antimicrobial activity was tested against a panel of microorganisms, including: Gram-negative
bacteria Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 9027), Proteus hauseri (ATCC
13315), Klebsiella pneumoniae (ATCC 10031), Salmonella enterica subsp. enterica serovar Enteritidis
(ATCC 13076), Gram-positive bacteria Staphylococcus aureus (ATCC 6538), Bacillus subtilis (ATCC 6633),
Clostridium sporogenes (ATCC 19404), yeasts Candida albicans (ATCC 10231), Saccharomyces cerevisiae
(ATCC 9763), and fungal strain Aspergillus brasiliensis (ATCC 16404).
Antimicrobial activity was evaluated using the broth microdilution method according to the
National Committee for Clinical Laboratory Standards [129]. The 96-well plates were prepared by
dispensing 100 µL of Mueller-Hinton broth for bacteria and Sabouraud dextrose broth for yeasts and
fungi into each well. Test extracts were dissolved in DMSO to a stock concentration of 20 mg/mL,
then 100 µL from the stock solution of the tested extracts were added to the first row of the plate
and double-diluted in the broth. The direct colony method was used in preparing the suspension of
bacteria and yeasts in sterile 0.9% saline, while preparation of the suspension of fungal spores included
gentle stripping of spores from agar slants with growing Aspergilli into sterile 0.9% saline. Suspension
turbidity was conducted by comparison with 0.5 McFarland standard. After measuring the optical
density OD600, the colony count was also checked after a series of dilutions of initial suspensions.
Due to the visual detection of growth inhibition, the maximum concentrations of microorganisms
were used. Ten µL of bacterial or yeast suspension or suspension of spores were added to each well
to give a final concentration of 106 CFU/mL for bacteria and 105 CFU/mL for yeasts and fungi. In
order to compare the activity of an extract with already existing, commercially available antimicrobial
agents, broad-spectrum compounds commonly used in such assays served as positive controls [130].
Chloramphenicol served as the positive control for bacteria, while nystatin served as the positive
control for yeasts and fungi. The inoculated plates were incubated at 37◦C for 24 h for bacteria and
at 28◦C for 48 h for the yeasts and fungi. The MIC was determined as the lowest concentration that
inhibited visible microbial growth.
Minimum bactericidal (MBC) and minimum fungicidal concentrations (MFC) were determined
by plating 10 µL of samples from wells where no colony growth was observed onto nutrient agar
medium for bacteria and Sabouraud dextrose agar for yeasts and fungi. After the incubation
period, the lowest concentration with no visible growth (no colony) was defined as the minimum
microbicidal concentration.
5. Conclusions
In this study, the influence of three extraction solvents (ethanol, dichloromethane, and sunflower oil)
on the composition, antioxidant, and antimicrobial activities of Helichrysum plicatum was investigated.
The extracts comprised very diverse groups of secondary metabolites, including terpenoids and
a myriad of (poly)phenolic compounds, flavonoids, α-pyrones, phloroglucinols, phenolic acids,
acetophenones, phthalides, and other phenolic derivatives. EE and DCME, both rich in α-pyrones,
possessed a marked antioxidant potential. DCME demonstrated the best antibacterial activity among
the extracts. All extracts displayed significant antifungal capabilities, with MIC values lower than or
equivalent to the MICs of the commercial antifungal agent nystatin. DCME had the lowest MIC values,
which could be a consequence of the presence of nonpolar polymethoxylated flavonoids. Based on the
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results from this study, H. plicatum extracts could be considered for use as natural additives in food
and cosmetic industries.
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